CJC1295 No DAC + IPA (10mg)

$100.00

● In Stock
Ready to Ship

Description

CJC-1295 No DAC + Ipamorelin is a synthetic peptide blend commonly studied in laboratory research involving growth hormone-releasing hormone (GHRH) signalling, ghrelin receptor activity and growth hormone secretion pathways.

Research & Laboratory Use Only

CJC-1295 No DAC + Ipamorelin is supplied by AusiGen strictly for controlled laboratory research, analytical testing and non-clinical scientific investigation only.

Not intended for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will handle and use these compounds in accordance with all applicable laws, regulations and laboratory requirements.

Key Research Areas

Dual Peptide Signalling Research — for non-clinical studies examining GHRH-related and growth hormone secretagogue signalling within controlled experimental models.
GHRH Receptor Research — used in laboratory investigation of growth hormone-releasing hormone receptor activity and associated downstream signalling pathways.
GHSR Pathway Research — suitable for controlled studies examining growth hormone secretagogue receptor activity and peptide-mediated signalling responses.
Pituitary Response Studies — for non-clinical research investigating peptide-related signalling and response mechanisms in controlled pituitary model systems.
GH/IGF-1 Pathway Research — applicable to analytical studies examining growth hormone signalling and associated downstream insulin-like growth factor pathways.
Receptor Interaction Analysis — used in controlled research comparing distinct peptide-receptor pathways, activation mechanisms and cellular responses.
Peptide Kinetics Research — suitable for laboratory investigation of peptide stability, degradation and time-dependent signalling behaviour.
Molecular Reference Work — applicable for compound identification, analytical comparison and laboratory research documentation.